This is generally for people with stage C or stage D heart failure based on the ACC/AHA system. There are four classes in the ...

The study enrolled 4128 patients 60 years and older with NYHA class II-IV symptoms and ejection fraction ≥45% who were hospitalized for heart failure during the last 6 months or had persistent ...

Aims In the Digitalis Investigation Group (DIG) trial, digoxin reduced mortality or hospitalization due to heart failure ... HF patients with NYHA class III–IV, LVEF <25%, or CTR >55%, and ...

Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein ≥2 mg/L; p=0.003) and ischemic HFrEF etiology ...

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment ...

An estimated 15 million U.S. adults are at risk for heart failure, according to a study published Dec. 17 in Annals of Internal Medicine. The figure was calculated using the American Heart Association ...

Heart failure outcomes in patients with type 2 diabetes receiving once-weekly exenatide are affected by left ventricular ejection fraction.